Cargando…
Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness–adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension
SUMMARY: In postmenopausal women with osteoporosis, up to 10 years of denosumab treatment significantly and continuously improved bone microarchitecture assessed by tissue thickness–adjusted trabecular bone score, independently of bone mineral density. Long-term denosumab treatment decreased the num...
Autores principales: | Hans, Didier, McDermott, Michele, Huang, Shuang, Kim, Min, Shevroja, Enisa, McClung, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202981/ https://www.ncbi.nlm.nih.gov/pubmed/36862192 http://dx.doi.org/10.1007/s00198-023-06708-8 |
Ejemplares similares
-
Updated trabecular bone score accounting for the soft tissue thickness (TBS(TT)) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis
por: Hans, Didier, et al.
Publicado: (2022) -
Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017) -
DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis
por: Shevroja, Enisa, et al.
Publicado: (2021) -
Type 2 Diabetes Mellitus Increases the Risk to Hip Fracture in Postmenopausal Osteoporosis by Deteriorating the Trabecular Bone Microarchitecture and Bone Mass
por: Mohsin, Sahar, et al.
Publicado: (2019) -
Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)